Anne Sydor

Dec 3, 2024 | jheor.org | Anne Sydor |Esteban Rivera |Robert Popovian

INTRODUCTION As with any complex U.S. federal legislation, the Inflation Reduction Act (IRA), signed into law on August 16, 2022, includes provisions with positive and negative consequences for diverse stakeholders.1 Specific clauses affect health insurance premiums, patients’ out-of-pocket costs, and wholesale medication prices that will impact patients, biopharmaceutical companies, the insurance industry, and policymakers differently, depending on their perspectives and roles within the...

Dec 3, 2024 | jheor.org | Anne Sydor |Esteban Rivera |Robert Popovian

INTRODUCTION As with any complex U.S. federal legislation, the Inflation Reduction Act (IRA), signed into law on August 16, 2022, includes provisions with positive and negative consequences for diverse stakeholders.1 Specific clauses affect health insurance premiums, patients’ out-of-pocket costs, and wholesale medication prices that will impact patients, biopharmaceutical companies, the insurance industry, and policymakers differently, depending on their perspectives and roles within the...

Jun 27, 2024 | medrxiv.org | Esteban Rivera |Anne Sydor |Robert Popovian

The Global Healthy Living Foundation (GHLF) relies on the activist philanthropy of our partners: academic partners, advocacy groups, corporate sponsors, foundations, and government agencies. We are grateful for their continued support of our community advocacy, education, and research efforts. A full list of GHLFpartners is available at ghlf.org/partners. Robert Popovian holds stock in multiple pharmaceutical companies and serves as a consultant to pharmaceutical companies.

Jun 27, 2024 | medrxiv.org | Esteban Rivera |Anne Sydor |Robert Popovian

The Global Healthy Living Foundation (GHLF) relies on the activist philanthropy of our partners: academic partners, advocacy groups, corporate sponsors, foundations, and government agencies. We are grateful for their continued support of our community advocacy, education, and research efforts. A full list of GHLFpartners is available at ghlf.org/partners. Robert Popovian holds stock in multiple pharmaceutical companies and serves as a consultant to pharmaceutical companies.

Nov 1, 2023 | itmedicalteam.pl | Anne Sydor |Robert Popovian |Sara Chea

AbstractObjective: Pharmacy Benefit Management companies (PBMs) often determine medication reimbursement, out of pocket costs, and access through formularies. Formularies were initially intended to ensure the use of cost-effective medication. Today, formularies are designed to maximize concessions (i.e., rebates, discounts, or fees) to PBMs from the biopharmaceutical industry.